1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Viral and Non-Viral Vector Manufacturing Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Viral Vectors
        1.2.3 Non-Viral Vectors
    1.3 Market by Application
        1.3.1 Global Viral and Non-Viral Vector Manufacturing Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Gene Therapy
        1.3.3 Vaccinology
        1.3.4 Cell Therapy
        1.3.5 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Viral and Non-Viral Vector Manufacturing Market Perspective (2017-2028)
    2.2 Viral and Non-Viral Vector Manufacturing Growth Trends by Region
        2.2.1 Viral and Non-Viral Vector Manufacturing Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Viral and Non-Viral Vector Manufacturing Historic Market Size by Region (2017-2022)
        2.2.3 Viral and Non-Viral Vector Manufacturing Forecasted Market Size by Region (2023-2028)
    2.3 Viral and Non-Viral Vector Manufacturing Market Dynamics
        2.3.1 Viral and Non-Viral Vector Manufacturing Industry Trends
        2.3.2 Viral and Non-Viral Vector Manufacturing Market Drivers
        2.3.3 Viral and Non-Viral Vector Manufacturing Market Challenges
        2.3.4 Viral and Non-Viral Vector Manufacturing Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Viral and Non-Viral Vector Manufacturing Players by Revenue
        3.1.1 Global Top Viral and Non-Viral Vector Manufacturing Players by Revenue (2017-2022)
        3.1.2 Global Viral and Non-Viral Vector Manufacturing Revenue Market Share by Players (2017-2022)
    3.2 Global Viral and Non-Viral Vector Manufacturing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Viral and Non-Viral Vector Manufacturing Revenue
    3.4 Global Viral and Non-Viral Vector Manufacturing Market Concentration Ratio
        3.4.1 Global Viral and Non-Viral Vector Manufacturing Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Viral and Non-Viral Vector Manufacturing Revenue in 2021
    3.5 Viral and Non-Viral Vector Manufacturing Key Players Head office and Area Served
    3.6 Key Players Viral and Non-Viral Vector Manufacturing Product Solution and Service
    3.7 Date of Enter into Viral and Non-Viral Vector Manufacturing Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Viral and Non-Viral Vector Manufacturing Breakdown Data by Type
    4.1 Global Viral and Non-Viral Vector Manufacturing Historic Market Size by Type (2017-2022)
    4.2 Global Viral and Non-Viral Vector Manufacturing Forecasted Market Size by Type (2023-2028)
5 Viral and Non-Viral Vector Manufacturing Breakdown Data by Application
    5.1 Global Viral and Non-Viral Vector Manufacturing Historic Market Size by Application (2017-2022)
    5.2 Global Viral and Non-Viral Vector Manufacturing Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Viral and Non-Viral Vector Manufacturing Market Size (2017-2028)
    6.2 North America Viral and Non-Viral Vector Manufacturing Market Size by Country (2017-2022)
    6.3 North America Viral and Non-Viral Vector Manufacturing Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Viral and Non-Viral Vector Manufacturing Market Size (2017-2028)
    7.2 Europe Viral and Non-Viral Vector Manufacturing Market Size by Country (2017-2022)
    7.3 Europe Viral and Non-Viral Vector Manufacturing Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Viral and Non-Viral Vector Manufacturing Market Size (2017-2028)
    8.2 Asia-Pacific Viral and Non-Viral Vector Manufacturing Market Size by Country (2017-2022)
    8.3 Asia-Pacific Viral and Non-Viral Vector Manufacturing Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Viral and Non-Viral Vector Manufacturing Market Size (2017-2028)
    9.2 Latin America Viral and Non-Viral Vector Manufacturing Market Size by Country (2017-2022)
    9.3 Latin America Viral and Non-Viral Vector Manufacturing Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Viral and Non-Viral Vector Manufacturing Market Size (2017-2028)
    10.2 Middle East & Africa Viral and Non-Viral Vector Manufacturing Market Size by Country (2017-2022)
    10.3 Middle East & Africa Viral and Non-Viral Vector Manufacturing Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Boehringer Ingelheim
        11.1.1 Boehringer Ingelheim Company Detail
        11.1.2 Boehringer Ingelheim Business Overview
        11.1.3 Boehringer Ingelheim Viral and Non-Viral Vector Manufacturing Introduction
        11.1.4 Boehringer Ingelheim Revenue in Viral and Non-Viral Vector Manufacturing Business (2017-2022)
        11.1.5 Boehringer Ingelheim Recent Development
    11.2 Catalent, Inc.
        11.2.1 Catalent, Inc. Company Detail
        11.2.2 Catalent, Inc. Business Overview
        11.2.3 Catalent, Inc. Viral and Non-Viral Vector Manufacturing Introduction
        11.2.4 Catalent, Inc. Revenue in Viral and Non-Viral Vector Manufacturing Business (2017-2022)
        11.2.5 Catalent, Inc. Recent Development
    11.3 FUJIFILM Holdings Corporation
        11.3.1 FUJIFILM Holdings Corporation Company Detail
        11.3.2 FUJIFILM Holdings Corporation Business Overview
        11.3.3 FUJIFILM Holdings Corporation Viral and Non-Viral Vector Manufacturing Introduction
        11.3.4 FUJIFILM Holdings Corporation Revenue in Viral and Non-Viral Vector Manufacturing Business (2017-2022)
        11.3.5 FUJIFILM Holdings Corporation Recent Development
    11.4 Danaher Corporation
        11.4.1 Danaher Corporation Company Detail
        11.4.2 Danaher Corporation Business Overview
        11.4.3 Danaher Corporation Viral and Non-Viral Vector Manufacturing Introduction
        11.4.4 Danaher Corporation Revenue in Viral and Non-Viral Vector Manufacturing Business (2017-2022)
        11.4.5 Danaher Corporation Recent Development
    11.5 Genscript Biotech Corporation
        11.5.1 Genscript Biotech Corporation Company Detail
        11.5.2 Genscript Biotech Corporation Business Overview
        11.5.3 Genscript Biotech Corporation Viral and Non-Viral Vector Manufacturing Introduction
        11.5.4 Genscript Biotech Corporation Revenue in Viral and Non-Viral Vector Manufacturing Business (2017-2022)
        11.5.5 Genscript Biotech Corporation Recent Development
    11.6 Lonza Group AG
        11.6.1 Lonza Group AG Company Detail
        11.6.2 Lonza Group AG Business Overview
        11.6.3 Lonza Group AG Viral and Non-Viral Vector Manufacturing Introduction
        11.6.4 Lonza Group AG Revenue in Viral and Non-Viral Vector Manufacturing Business (2017-2022)
        11.6.5 Lonza Group AG Recent Development
    11.7 Merck KGaA Inc.
        11.7.1 Merck KGaA Inc. Company Detail
        11.7.2 Merck KGaA Inc. Business Overview
        11.7.3 Merck KGaA Inc. Viral and Non-Viral Vector Manufacturing Introduction
        11.7.4 Merck KGaA Inc. Revenue in Viral and Non-Viral Vector Manufacturing Business (2017-2022)
        11.7.5 Merck KGaA Inc. Recent Development
    11.8 Oxford Biomedica Plc
        11.8.1 Oxford Biomedica Plc Company Detail
        11.8.2 Oxford Biomedica Plc Business Overview
        11.8.3 Oxford Biomedica Plc Viral and Non-Viral Vector Manufacturing Introduction
        11.8.4 Oxford Biomedica Plc Revenue in Viral and Non-Viral Vector Manufacturing Business (2017-2022)
        11.8.5 Oxford Biomedica Plc Recent Development
    11.9 Sartorius AG
        11.9.1 Sartorius AG Company Detail
        11.9.2 Sartorius AG Business Overview
        11.9.3 Sartorius AG Viral and Non-Viral Vector Manufacturing Introduction
        11.9.4 Sartorius AG Revenue in Viral and Non-Viral Vector Manufacturing Business (2017-2022)
        11.9.5 Sartorius AG Recent Development
    11.10 Takara Bio Inc.
        11.10.1 Takara Bio Inc. Company Detail
        11.10.2 Takara Bio Inc. Business Overview
        11.10.3 Takara Bio Inc. Viral and Non-Viral Vector Manufacturing Introduction
        11.10.4 Takara Bio Inc. Revenue in Viral and Non-Viral Vector Manufacturing Business (2017-2022)
        11.10.5 Takara Bio Inc. Recent Development
    11.11 Thermo Fisher Scientific Inc.
        11.11.1 Thermo Fisher Scientific Inc. Company Detail
        11.11.2 Thermo Fisher Scientific Inc. Business Overview
        11.11.3 Thermo Fisher Scientific Inc. Viral and Non-Viral Vector Manufacturing Introduction
        11.11.4 Thermo Fisher Scientific Inc. Revenue in Viral and Non-Viral Vector Manufacturing Business (2017-2022)
        11.11.5 Thermo Fisher Scientific Inc. Recent Development
    11.12 Wuxi AppTec
        11.12.1 Wuxi AppTec Company Detail
        11.12.2 Wuxi AppTec Business Overview
        11.12.3 Wuxi AppTec Viral and Non-Viral Vector Manufacturing Introduction
        11.12.4 Wuxi AppTec Revenue in Viral and Non-Viral Vector Manufacturing Business (2017-2022)
        11.12.5 Wuxi AppTec Recent Development
    11.13 Acuitas Therapeutics
        11.13.1 Acuitas Therapeutics Company Detail
        11.13.2 Acuitas Therapeutics Business Overview
        11.13.3 Acuitas Therapeutics Viral and Non-Viral Vector Manufacturing Introduction
        11.13.4 Acuitas Therapeutics Revenue in Viral and Non-Viral Vector Manufacturing Business (2017-2022)
        11.13.5 Acuitas Therapeutics Recent Development
    11.14 Evonik Industries AG
        11.14.1 Evonik Industries AG Company Detail
        11.14.2 Evonik Industries AG Business Overview
        11.14.3 Evonik Industries AG Viral and Non-Viral Vector Manufacturing Introduction
        11.14.4 Evonik Industries AG Revenue in Viral and Non-Viral Vector Manufacturing Business (2017-2022)
        11.14.5 Evonik Industries AG Recent Development
    11.15 Exelead, Inc.
        11.15.1 Exelead, Inc. Company Detail
        11.15.2 Exelead, Inc. Business Overview
        11.15.3 Exelead, Inc. Viral and Non-Viral Vector Manufacturing Introduction
        11.15.4 Exelead, Inc. Revenue in Viral and Non-Viral Vector Manufacturing Business (2017-2022)
        11.15.5 Exelead, Inc. Recent Development
    11.16 Entos Pharmaceuticals
        11.16.1 Entos Pharmaceuticals Company Detail
        11.16.2 Entos Pharmaceuticals Business Overview
        11.16.3 Entos Pharmaceuticals Viral and Non-Viral Vector Manufacturing Introduction
        11.16.4 Entos Pharmaceuticals Revenue in Viral and Non-Viral Vector Manufacturing Business (2017-2022)
        11.16.5 Entos Pharmaceuticals Recent Development
    11.17 Genevant Sciences GmbH
        11.17.1 Genevant Sciences GmbH Company Detail
        11.17.2 Genevant Sciences GmbH Business Overview
        11.17.3 Genevant Sciences GmbH Viral and Non-Viral Vector Manufacturing Introduction
        11.17.4 Genevant Sciences GmbH Revenue in Viral and Non-Viral Vector Manufacturing Business (2017-2022)
        11.17.5 Genevant Sciences GmbH Recent Development
    11.18 T&T Scientific Corporation
        11.18.1 T&T Scientific Corporation Company Detail
        11.18.2 T&T Scientific Corporation Business Overview
        11.18.3 T&T Scientific Corporation Viral and Non-Viral Vector Manufacturing Introduction
        11.18.4 T&T Scientific Corporation Revenue in Viral and Non-Viral Vector Manufacturing Business (2017-2022)
        11.18.5 T&T Scientific Corporation Recent Development
    11.19 Moderna, Inc.
        11.19.1 Moderna, Inc. Company Detail
        11.19.2 Moderna, Inc. Business Overview
        11.19.3 Moderna, Inc. Viral and Non-Viral Vector Manufacturing Introduction
        11.19.4 Moderna, Inc. Revenue in Viral and Non-Viral Vector Manufacturing Business (2017-2022)
        11.19.5 Moderna, Inc. Recent Development
    11.20 CureVac N.V.
        11.20.1 CureVac N.V. Company Detail
        11.20.2 CureVac N.V. Business Overview
        11.20.3 CureVac N.V. Viral and Non-Viral Vector Manufacturing Introduction
        11.20.4 CureVac N.V. Revenue in Viral and Non-Viral Vector Manufacturing Business (2017-2022)
        11.20.5 CureVac N.V. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
                  
              

                

                 
List of Tables
    Table 1. Global Viral and Non-Viral Vector Manufacturing Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Viral Vectors
    Table 3. Key Players of Non-Viral Vectors
    Table 4. Global Viral and Non-Viral Vector Manufacturing Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 5. Global Viral and Non-Viral Vector Manufacturing Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Viral and Non-Viral Vector Manufacturing Market Size by Region (2017-2022) & (US$ Million)
    Table 7. Global Viral and Non-Viral Vector Manufacturing Market Share by Region (2017-2022)
    Table 8. Global Viral and Non-Viral Vector Manufacturing Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 9. Global Viral and Non-Viral Vector Manufacturing Market Share by Region (2023-2028)
    Table 10. Viral and Non-Viral Vector Manufacturing Market Trends
    Table 11. Viral and Non-Viral Vector Manufacturing Market Drivers
    Table 12. Viral and Non-Viral Vector Manufacturing Market Challenges
    Table 13. Viral and Non-Viral Vector Manufacturing Market Restraints
    Table 14. Global Viral and Non-Viral Vector Manufacturing Revenue by Players (2017-2022) & (US$ Million)
    Table 15. Global Viral and Non-Viral Vector Manufacturing Market Share by Players (2017-2022)
    Table 16. Global Top Viral and Non-Viral Vector Manufacturing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral and Non-Viral Vector Manufacturing as of 2021)
    Table 17. Ranking of Global Top Viral and Non-Viral Vector Manufacturing Companies by Revenue (US$ Million) in 2021
    Table 18. Global 5 Largest Players Market Share by Viral and Non-Viral Vector Manufacturing Revenue (CR5 and HHI) & (2017-2022)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Viral and Non-Viral Vector Manufacturing Product Solution and Service
    Table 21. Date of Enter into Viral and Non-Viral Vector Manufacturing Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Viral and Non-Viral Vector Manufacturing Market Size by Type (2017-2022) & (US$ Million)
    Table 24. Global Viral and Non-Viral Vector Manufacturing Revenue Market Share by Type (2017-2022)
    Table 25. Global Viral and Non-Viral Vector Manufacturing Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 26. Global Viral and Non-Viral Vector Manufacturing Revenue Market Share by Type (2023-2028)
    Table 27. Global Viral and Non-Viral Vector Manufacturing Market Size by Application (2017-2022) & (US$ Million)
    Table 28. Global Viral and Non-Viral Vector Manufacturing Revenue Market Share by Application (2017-2022)
    Table 29. Global Viral and Non-Viral Vector Manufacturing Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 30. Global Viral and Non-Viral Vector Manufacturing Revenue Market Share by Application (2023-2028)
    Table 31. North America Viral and Non-Viral Vector Manufacturing Market Size by Country (2017-2022) & (US$ Million)
    Table 32. North America Viral and Non-Viral Vector Manufacturing Market Size by Country (2023-2028) & (US$ Million)
    Table 33. Europe Viral and Non-Viral Vector Manufacturing Market Size by Country (2017-2022) & (US$ Million)
    Table 34. Europe Viral and Non-Viral Vector Manufacturing Market Size by Country (2023-2028) & (US$ Million)
    Table 35. Asia-Pacific Viral and Non-Viral Vector Manufacturing Market Size by Region (2017-2022) & (US$ Million)
    Table 36. Asia-Pacific Viral and Non-Viral Vector Manufacturing Market Size by Region (2023-2028) & (US$ Million)
    Table 37. Latin America Viral and Non-Viral Vector Manufacturing Market Size by Country (2017-2022) & (US$ Million)
    Table 38. Latin America Viral and Non-Viral Vector Manufacturing Market Size by Country (2023-2028) & (US$ Million)
    Table 39. Middle East & Africa Viral and Non-Viral Vector Manufacturing Market Size by Country (2017-2022) & (US$ Million)
    Table 40. Middle East & Africa Viral and Non-Viral Vector Manufacturing Market Size by Country (2023-2028) & (US$ Million)
    Table 41. Boehringer Ingelheim Company Detail
    Table 42. Boehringer Ingelheim Business Overview
    Table 43. Boehringer Ingelheim Viral and Non-Viral Vector Manufacturing Product
    Table 44. Boehringer Ingelheim Revenue in Viral and Non-Viral Vector Manufacturing Business (2017-2022) & (US$ Million)
    Table 45. Boehringer Ingelheim Recent Development
    Table 46. Catalent, Inc. Company Detail
    Table 47. Catalent, Inc. Business Overview
    Table 48. Catalent, Inc. Viral and Non-Viral Vector Manufacturing Product
    Table 49. Catalent, Inc. Revenue in Viral and Non-Viral Vector Manufacturing Business (2017-2022) & (US$ Million)
    Table 50. Catalent, Inc. Recent Development
    Table 51. FUJIFILM Holdings Corporation Company Detail
    Table 52. FUJIFILM Holdings Corporation Business Overview
    Table 53. FUJIFILM Holdings Corporation Viral and Non-Viral Vector Manufacturing Product
    Table 54. FUJIFILM Holdings Corporation Revenue in Viral and Non-Viral Vector Manufacturing Business (2017-2022) & (US$ Million)
    Table 55. FUJIFILM Holdings Corporation Recent Development
    Table 56. Danaher Corporation Company Detail
    Table 57. Danaher Corporation Business Overview
    Table 58. Danaher Corporation Viral and Non-Viral Vector Manufacturing Product
    Table 59. Danaher Corporation Revenue in Viral and Non-Viral Vector Manufacturing Business (2017-2022) & (US$ Million)
    Table 60. Danaher Corporation Recent Development
    Table 61. Genscript Biotech Corporation Company Detail
    Table 62. Genscript Biotech Corporation Business Overview
    Table 63. Genscript Biotech Corporation Viral and Non-Viral Vector Manufacturing Product
    Table 64. Genscript Biotech Corporation Revenue in Viral and Non-Viral Vector Manufacturing Business (2017-2022) & (US$ Million)
    Table 65. Genscript Biotech Corporation Recent Development
    Table 66. Lonza Group AG Company Detail
    Table 67. Lonza Group AG Business Overview
    Table 68. Lonza Group AG Viral and Non-Viral Vector Manufacturing Product
    Table 69. Lonza Group AG Revenue in Viral and Non-Viral Vector Manufacturing Business (2017-2022) & (US$ Million)
    Table 70. Lonza Group AG Recent Development
    Table 71. Merck KGaA Inc. Company Detail
    Table 72. Merck KGaA Inc. Business Overview
    Table 73. Merck KGaA Inc. Viral and Non-Viral Vector Manufacturing Product
    Table 74. Merck KGaA Inc. Revenue in Viral and Non-Viral Vector Manufacturing Business (2017-2022) & (US$ Million)
    Table 75. Merck KGaA Inc. Recent Development
    Table 76. Oxford Biomedica Plc Company Detail
    Table 77. Oxford Biomedica Plc Business Overview
    Table 78. Oxford Biomedica Plc Viral and Non-Viral Vector Manufacturing Product
    Table 79. Oxford Biomedica Plc Revenue in Viral and Non-Viral Vector Manufacturing Business (2017-2022) & (US$ Million)
    Table 80. Oxford Biomedica Plc Recent Development
    Table 81. Sartorius AG Company Detail
    Table 82. Sartorius AG Business Overview
    Table 83. Sartorius AG Viral and Non-Viral Vector Manufacturing Product
    Table 84. Sartorius AG Revenue in Viral and Non-Viral Vector Manufacturing Business (2017-2022) & (US$ Million)
    Table 85. Sartorius AG Recent Development
    Table 86. Takara Bio Inc. Company Detail
    Table 87. Takara Bio Inc. Business Overview
    Table 88. Takara Bio Inc. Viral and Non-Viral Vector Manufacturing Product
    Table 89. Takara Bio Inc. Revenue in Viral and Non-Viral Vector Manufacturing Business (2017-2022) & (US$ Million)
    Table 90. Takara Bio Inc. Recent Development
    Table 91. Thermo Fisher Scientific Inc. Company Detail
    Table 92. Thermo Fisher Scientific Inc. Business Overview
    Table 93. Thermo Fisher Scientific Inc. Viral and Non-Viral Vector ManufacturingProduct
    Table 94. Thermo Fisher Scientific Inc. Revenue in Viral and Non-Viral Vector Manufacturing Business (2017-2022) & (US$ Million)
    Table 95. Thermo Fisher Scientific Inc. Recent Development
    Table 96. Wuxi AppTec Company Detail
    Table 97. Wuxi AppTec Business Overview
    Table 98. Wuxi AppTec Viral and Non-Viral Vector ManufacturingProduct
    Table 99. Wuxi AppTec Revenue in Viral and Non-Viral Vector Manufacturing Business (2017-2022) & (US$ Million)
    Table 100. Wuxi AppTec Recent Development
    Table 101. Acuitas Therapeutics Company Detail
    Table 102. Acuitas Therapeutics Business Overview
    Table 103. Acuitas Therapeutics Viral and Non-Viral Vector ManufacturingProduct
    Table 104. Acuitas Therapeutics Revenue in Viral and Non-Viral Vector Manufacturing Business (2017-2022) & (US$ Million)
    Table 105. Acuitas Therapeutics Recent Development
    Table 106. Evonik Industries AG Company Detail
    Table 107. Evonik Industries AG Business Overview
    Table 108. Evonik Industries AG Viral and Non-Viral Vector ManufacturingProduct
    Table 109. Evonik Industries AG Revenue in Viral and Non-Viral Vector Manufacturing Business (2017-2022) & (US$ Million)
    Table 110. Evonik Industries AG Recent Development
    Table 111. Exelead, Inc. Company Detail
    Table 112. Exelead, Inc. Business Overview
    Table 113. Exelead, Inc. Viral and Non-Viral Vector ManufacturingProduct
    Table 114. Exelead, Inc. Revenue in Viral and Non-Viral Vector Manufacturing Business (2017-2022) & (US$ Million)
    Table 115. Exelead, Inc. Recent Development
    Table 116. Entos Pharmaceuticals Company Detail
    Table 117. Entos Pharmaceuticals Business Overview
    Table 118. Entos Pharmaceuticals Viral and Non-Viral Vector ManufacturingProduct
    Table 119. Entos Pharmaceuticals Revenue in Viral and Non-Viral Vector Manufacturing Business (2017-2022) & (US$ Million)
    Table 120. Entos Pharmaceuticals Recent Development
    Table 121. Genevant Sciences GmbH Company Detail
    Table 122. Genevant Sciences GmbH Business Overview
    Table 123. Genevant Sciences GmbH Viral and Non-Viral Vector ManufacturingProduct
    Table 124. Genevant Sciences GmbH Revenue in Viral and Non-Viral Vector Manufacturing Business (2017-2022) & (US$ Million)
    Table 125. Genevant Sciences GmbH Recent Development
    Table 126. T&T Scientific Corporation Company Detail
    Table 127. T&T Scientific Corporation Business Overview
    Table 128. T&T Scientific Corporation Viral and Non-Viral Vector ManufacturingProduct
    Table 129. T&T Scientific Corporation Revenue in Viral and Non-Viral Vector Manufacturing Business (2017-2022) & (US$ Million)
    Table 130. T&T Scientific Corporation Recent Development
    Table 131. Moderna, Inc. Company Detail
    Table 132. Moderna, Inc. Business Overview
    Table 133. Moderna, Inc. Viral and Non-Viral Vector ManufacturingProduct
    Table 134. Moderna, Inc. Revenue in Viral and Non-Viral Vector Manufacturing Business (2017-2022) & (US$ Million)
    Table 135. Moderna, Inc. Recent Development
    Table 136. CureVac N.V. Company Detail
    Table 137. CureVac N.V. Business Overview
    Table 138. CureVac N.V. Viral and Non-Viral Vector ManufacturingProduct
    Table 139. CureVac N.V. Revenue in Viral and Non-Viral Vector Manufacturing Business (2017-2022) & (US$ Million)
    Table 140. CureVac N.V. Recent Development
    Table 141. Research Programs/Design for This Report
    Table 142. Key Data Information from Secondary Sources
    Table 143. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Viral and Non-Viral Vector Manufacturing Market Share by Type: 2021 VS 2028
    Figure 2. Viral Vectors Features
    Figure 3. Non-Viral Vectors Features
    Figure 4. Global Viral and Non-Viral Vector Manufacturing Market Share by Application in 2021 & 2028
    Figure 5. Gene Therapy Case Studies
    Figure 6. Vaccinology Case Studies
    Figure 7. Cell Therapy Case Studies
    Figure 8. Others Case Studies
    Figure 9. Viral and Non-Viral Vector Manufacturing Report Years Considered
    Figure 10. Global Viral and Non-Viral Vector Manufacturing Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 11. Global Viral and Non-Viral Vector Manufacturing Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global Viral and Non-Viral Vector Manufacturing Market Share by Region: 2021 VS 2028
    Figure 13. Global Viral and Non-Viral Vector Manufacturing Market Share by Players in 2021
    Figure 14. Global Top Viral and Non-Viral Vector Manufacturing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral and Non-Viral Vector Manufacturing as of 2021)
    Figure 15. The Top 10 and 5 Players Market Share by Viral and Non-Viral Vector Manufacturing Revenue in 2021
    Figure 16. North America Viral and Non-Viral Vector Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 17. North America Viral and Non-Viral Vector Manufacturing Market Share by Country (2017-2028)
    Figure 18. United States Viral and Non-Viral Vector Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. Canada Viral and Non-Viral Vector Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Europe Viral and Non-Viral Vector Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Europe Viral and Non-Viral Vector Manufacturing Market Share by Country (2017-2028)
    Figure 22. Germany Viral and Non-Viral Vector Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. France Viral and Non-Viral Vector Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. U.K. Viral and Non-Viral Vector Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Italy Viral and Non-Viral Vector Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Russia Viral and Non-Viral Vector Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Nordic Countries Viral and Non-Viral Vector Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Asia-Pacific Viral and Non-Viral Vector Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Asia-Pacific Viral and Non-Viral Vector Manufacturing Market Share by Region (2017-2028)
    Figure 30. China Viral and Non-Viral Vector Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Japan Viral and Non-Viral Vector Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. South Korea Viral and Non-Viral Vector Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Southeast Asia Viral and Non-Viral Vector Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. India Viral and Non-Viral Vector Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Australia Viral and Non-Viral Vector Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Latin America Viral and Non-Viral Vector Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Latin America Viral and Non-Viral Vector Manufacturing Market Share by Country (2017-2028)
    Figure 38. Mexico Viral and Non-Viral Vector Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Brazil Viral and Non-Viral Vector Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Middle East & Africa Viral and Non-Viral Vector Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Middle East & Africa Viral and Non-Viral Vector Manufacturing Market Share by Country (2017-2028)
    Figure 42. Turkey Viral and Non-Viral Vector Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Saudi Arabia Viral and Non-Viral Vector Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Boehringer Ingelheim Revenue Growth Rate in Viral and Non-Viral Vector Manufacturing Business (2017-2022)
    Figure 45. Catalent, Inc. Revenue Growth Rate in Viral and Non-Viral Vector Manufacturing Business (2017-2022)
    Figure 46. FUJIFILM Holdings Corporation Revenue Growth Rate in Viral and Non-Viral Vector Manufacturing Business (2017-2022)
    Figure 47. Danaher Corporation Revenue Growth Rate in Viral and Non-Viral Vector Manufacturing Business (2017-2022)
    Figure 48. Genscript Biotech Corporation Revenue Growth Rate in Viral and Non-Viral Vector Manufacturing Business (2017-2022)
    Figure 49. Lonza Group AG Revenue Growth Rate in Viral and Non-Viral Vector Manufacturing Business (2017-2022)
    Figure 50. Merck KGaA Inc. Revenue Growth Rate in Viral and Non-Viral Vector Manufacturing Business (2017-2022)
    Figure 51. Oxford Biomedica Plc Revenue Growth Rate in Viral and Non-Viral Vector Manufacturing Business (2017-2022)
    Figure 52. Sartorius AG Revenue Growth Rate in Viral and Non-Viral Vector Manufacturing Business (2017-2022)
    Figure 53. Takara Bio Inc. Revenue Growth Rate in Viral and Non-Viral Vector Manufacturing Business (2017-2022)
    Figure 54. Thermo Fisher Scientific Inc. Revenue Growth Rate in Viral and Non-Viral Vector Manufacturing Business (2017-2022)
    Figure 55. Wuxi AppTec Revenue Growth Rate in Viral and Non-Viral Vector Manufacturing Business (2017-2022)
    Figure 56. Acuitas Therapeutics Revenue Growth Rate in Viral and Non-Viral Vector Manufacturing Business (2017-2022)
    Figure 57. Evonik Industries AG Revenue Growth Rate in Viral and Non-Viral Vector Manufacturing Business (2017-2022)
    Figure 58. Exelead, Inc. Revenue Growth Rate in Viral and Non-Viral Vector Manufacturing Business (2017-2022)
    Figure 59. Entos Pharmaceuticals Revenue Growth Rate in Viral and Non-Viral Vector Manufacturing Business (2017-2022)
    Figure 60. Genevant Sciences GmbH Revenue Growth Rate in Viral and Non-Viral Vector Manufacturing Business (2017-2022)
    Figure 61. T&T Scientific Corporation Revenue Growth Rate in Viral and Non-Viral Vector Manufacturing Business (2017-2022)
    Figure 62. Moderna, Inc. Revenue Growth Rate in Viral and Non-Viral Vector Manufacturing Business (2017-2022)
    Figure 63. CureVac N.V. Revenue Growth Rate in Viral and Non-Viral Vector Manufacturing Business (2017-2022)
    Figure 64. Bottom-up and Top-down Approaches for This Report
    Figure 65. Data Triangulation
    Figure 66. Key Executives Interviewed